The results of the dissolution tests performed for a model formulation containing
ionizable compounds (Nexium 20 mg mups) indicate that both the simulated fasting intraluminal pHprofiles and the buffer species can significantly affect the dissolution process by changing the lag time
prior to initial drug release and the release rate of the model compound.